Inactivated- or Killed-Virus HIV/AIDS Vaccines

E-ISSN： 1875-5852|5|2|131-141

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.5, Iss.2, 2005-06, pp. : 131-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Immunity and DNA Vaccines for the Treatment of HIV / AIDS

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Etravirine for the treatment of HIV/AIDS

By Schrijvers Rik

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1087-1096

Informa Healthcare

Access to resources Recommend Favorite

Nanomedicines as Therapeutics in HIV-AIDS

Pharmaceutical Nanotechnology, Vol. 4, Iss. 4, 2016-12 ,pp. : 255-266

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Broadly Reactive HIV-1/AIDS Vaccines: A Review of Polyvalent and Centralized HIV-1 Vaccines

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1957-1964

Bentham Science Publishers

Access to resources Recommend Favorite

Access to HIV/AIDS drugs widens

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite